Author: Multibagger News

Title: “Breaking News: U.S. Inflation Unchanged in July, Setting Stage for Fed Rate Cut in September” Investing.com — In a recent report by the Bureau of Economic Analysis, it was revealed that overall annual U.S. inflation remained unchanged in July, setting the stage for a potential interest rate cut by the U.S. Federal Reserve in September. The Personal Consumption Expenditures (PCE) price index came in at 2.5% in July, matching the previous month and falling below the expected 2.6%. When excluding volatile items like food and fuel, the core PCE index, the Fed’s preferred measure of inflation, also remained steady…

Read More

UBS Downgrades Japanese Equities to "Sell": Why Europe and UK Are the New Investment Hotspots Introduction In a significant move, UBS has downgraded Japanese equities to a "sell" rating, pivoting its investment strategy towards European and UK markets. This decision is rooted in a detailed analysis of several economic and market dynamics that favor Europe and the UK over Japan. Key Factors Behind UBS’s Decision Structural and Cyclical Challenges in Japan Despite Japan’s structural improvements, UBS analysts identify several cyclical challenges that make Japanese stocks less attractive. These include: High Operational Leverage: Japanese corporate earnings are highly sensitive to global…

Read More

Investing.com: U.S. Inflation Unchanged in July, Setting the Stage for Fed Rate Cut In July, overall annual U.S. inflation remained steady, setting the stage for a potential interest rate cut by the U.S. Federal Reserve in September. According to data from the Bureau of Economic Analysis, the Personal Consumption Expenditures (PCE) price index held at 2.5%, staying flat from the previous month and below the expected 2.6%. Excluding volatile items like food and fuel, the core PCE price index, the Fed’s preferred measure of inflation, also remained unchanged at 2.6%, falling below the expected 2.7%. Both figures saw a month-on-month…

Read More

Emergent BioSolutions’ ACAM2000 Smallpox Vaccine Receives FDA Approval for High-Risk Individuals, Shares Surge 15% In a major development, the U.S. Food and Drug Administration has granted expanded approval to Emergent BioSolutions’ smallpox vaccine, ACAM2000, for use in individuals at high risk of mpox infection. This announcement has caused a significant surge of 15% in the drugmaker’s shares before the bell on Friday. ACAM2000 becomes the second approved shot against mpox in the United States, following Bavarian Nordic’s Jynneos. It is important to note that individuals with weakened immune systems, including those with HIV, cannot take the Emergent vaccine. Despite being…

Read More

MongoDB (NASDAQ: MDB) Shares Surge 13% After Strong Q2 Earnings Report | Mizuho Raises Price Target to $275 On Friday, Mizuho raised its price target on MongoDB shares to $275 from $250, maintaining a Neutral rating. The revision followed MongoDB’s second-quarter earnings report, which surpassed consensus expectations for revenue and margins. The company’s management team also increased its fiscal year 2025 growth forecast to 14-15%, exceeding the consensus of 13%. This announcement resulted in a 13% rise in MongoDB’s shares in after-hours trading. MongoDB’s positive quarter was attributed to significant new workload acquisitions and slightly better-than-anticipated trends in Atlas consumption.…

Read More

Hedge Funds’ Performance in July 2023: Analyzing Gains Amid Market Volatility Hedge funds demonstrated a moderate performance in July, climbing 1.2% for the month and achieving a 6.4% year-to-date (YTD) increase, as highlighted in a recent UBS report. However, they lagged behind equities and bonds, mainly due to challenges in macro and relative value strategies. Directional strategies, on the other hand, led performance with positive alpha across most strategies, benefiting from significantly lower volatility compared to equities and bonds. Choppy Market Conditions and AI Stock Concerns The month of July was characterized by volatile market conditions, with equities undergoing a…

Read More

Global Bond Funds See Highest Weekly Inflow in Six Weeks Amid Fed Rate Cut Anticipation and Middle East Tensions Global bond funds received a significant boost in the seven days to Aug. 28, attracting the largest weekly inflow in six weeks. Investors flocked to government bonds in anticipation of a September Fed rate cut and ongoing tensions in the Middle East. According to LSEG data, investors poured in a net total of $17.69 billion into global bond funds during the week, marking the largest weekly net purchase since July 17. The two-year U.S. Treasury yield, a key indicator of interest-rate…

Read More

Thailand’s Anti-Graft Body Probes 44 Move Forward Party Members Over Royal Law Amendment Support In a recent development, Thailand’s anti-graft body has launched an investigation into 44 members of the disbanded Move Forward party. These members are being probed following a complaint seeking their lifetime bans from politics for supporting legislation aimed at amending a law against royal insults. The Move Forward party, which was dissolved by a court less than a month ago, had campaigned on amending the law that protects the powerful crown from criticism. Among the 44 individuals under investigation are 25 current lawmakers of the People’s…

Read More

Gossamer Bio Inc (GOSS) Receives Buy Rating Ahead of ERS Congress: Analysts Optimistic About Potential of Seralutinib as Treatment for PAH On Friday, H.C. Wainwright reiterated a Buy rating and $10.00 price target for Gossamer Bio Inc (GOSS) stock, in anticipation of data presentations at the upcoming European Respiratory Society (ERS) Congress 2024. The company is set to present findings from the TORREY-OLE Phase 2 trial of seralutinib, an inhaled tyrosine kinase inhibitor, which aims to demonstrate sustained effects beyond 24 weeks for patients with pulmonary arterial hypertension (PAH). Gossamer Bio also provided updates on its pipeline, with expectations of…

Read More

Why Long-Only Funds Are Betting Big on Communication Services: A Breakdown for Your Financial Future In the second quarter, long-only funds (LOs) have made a decisive move by significantly increasing their exposure to Communication Services, boosting their relative weight in the sector by five percentage points to over 30% overweight, according to a recent update from Bank of America (BofA). Shift in Strategy: Communication Services Take the Lead BofA’s active managers holding update reveals a growing confidence in the Communication Services sector, a sector already deemed "the most crowded." This strategic reallocation underscores the perceived stability and potential growth in…

Read More